Journal article

Somatosensation assessment using the NIH Toolbox

Winnie Dunn, James W Griffith, M Tracy Morrison, Jennifer Tanquary, Dory Sabata, David Victorson, Leeanne M Carey, Richard C Gershon

Neurology | LIPPINCOTT WILLIAMS & WILKINS | Published : 2013

Grants

Awarded by Blueprint for Neuroscience Research, NIH


Awarded by NIH


Awarded by Australian Research Council


Awarded by National Health and Medical Research Council of Australia


Awarded by NINDS


Awarded by NHLBI K23


Awarded by NIA


Awarded by NIDRR


Awarded by OppNet


Awarded by EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT


Awarded by NATIONAL CANCER INSTITUTE


Awarded by NATIONAL HEART, LUNG, AND BLOOD INSTITUTE


Awarded by NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES


Awarded by NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES


Awarded by NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE


Awarded by NATIONAL INSTITUTE ON AGING


Funding Acknowledgements

This study is funded in whole or in part with Federal funds from the Blueprint for Neuroscience Research, NIH, under contract no. HHS-N-260-2006-00007-C.W. Dunn is the author of the Sensory Profile measures, which are published by Pearson Inc. Pearson Inc. owns the copyright on these tests, and Dr. Dunn receives a royalty when they are sold. J. Griffith has received financial support from NorthShore University HealthSystem, the Cleveland Clinic Foundation/Teva Neurosciences, Inc., Ironwood Pharmaceuticals, Inc., Forest Laboratories, Inc., the NIH, the Department of Defense-United States Army, and the FWO, Belgium. In addition to NIH Toolbox funding, he receives funding from the NIH for other research (grant U01 DK082342). He has also been a paid consultant to Dr. Kathryn Grant of DePaul University, and maintains a clinical psychology practice for which he bills for his services. T. Morrison, J. Tanquary, and D. Sabata report no disclosures. D. Victorson holds stock options in Eli Lily and Company, received an honoraria for serving on the Steering Committee of the Reeve Neuro-Recovery Network, was funded by NIH contracts HHSN265200423601C and HHS-N-260-2006-00007-C and grants R01HD054569-02NIDRR, 1U01NS056975-01, and R01 CA104883, received support from the American Cancer Society (national and Illinois Division) for research in prostate cancer, received institutional support from NorthShore University HealthCare System for research in prostate cancer, received institutional support from the Medical University of South Carolina for sarcoidosis research, and received institutional support from the Northwestern Medical Faculty Foundation for urology research. L. Carey is supported by an Australian Research Council Future Fellowship (no. FT0992299) and was previously supported by a National Health and Medical Research Council of Australia Career Development Award (no. 307905). Dr. Carey is an expert consultant for the NIH Toolbox Project. R. Gershon has received personal compensation for activities as a speaker and consultant with Sylvan Learning, Rockman, and the American Board of Podiatric Surgery. He has several grants awarded by NIH: N01-AG-6-0007, 1U5AR057943-01, HHSN260200600007, 1U01DK082342-01, AG-260-06-01, HD05469; NINDS: U01 NS 056 975 02; NHLBI K23: K23HL085766; NIA: 1RC2AG036498-01; NIDRR: H133B090024; and OppNet: N01-AG-6-0007. Go to Neurology. org for full disclosures.